No Data
No Data
No Data
No Data
No Data
Renhe Pharmacy Gets 58 Million Yuan in Government Grants
Renhe Pharmacy (SHE:000650) received 58.4 million yuan in income-related enterprise support funds from the municipality of China's Zhangshu City, according to the company's filing on the Shenzhen Stoc
MT NewswiresApr 15 04:18 ET
Renhe Pharmaceutical (000650.SZ): The repurchase has completed a cumulative total of 1.107% shares have been repurchased
Gelonghui, April 1, 丨 Renhe Pharmaceutical (000650.SZ) announced that the time period for the company's actual share repurchase was from December 8, 2023 to March 29, 2024. The cumulative number of shares repurchased through centralized bidding transactions through the repurchase special securities account was 15,500,000 shares, accounting for 1.1072% of the company's total share capital. The maximum transaction price of the repurchase was 6.78 yuan/share, and the minimum transaction price was 5.18 yuan/share, and the total transaction amount was about RMB 100 million (excluding transaction fees).
Gelonghui FinanceApr 1 03:50 ET
Has Renhe Pharmacy Co., Ltd.'s (SZSE:000650) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Renhe Pharmacy's (SZSE:000650) stock is up by a considerable 8.6% over the past month. Given that stock prices are usually aligned with a company's financial performance in the long-term, we decided
Simply Wall StMar 14 22:30 ET
Renhe Pharmaceutical (000650.SZ) subsidiary obtained the drug registration certificate for sodium hyaluronate eye drops
Renhe Pharmaceutical (000650.SZ) issued an announcement. The company's subsidiary Jiangxi Shanliang Pharmaceutical Co., Ltd. recently received the national...
Zhitong FinanceMar 3 22:44 ET
Renhe Pharmaceutical (000650.SZ): 1.00% of shares have been cumulatively repurchased
Gelonghui on March 1, 丨 Renhe Pharmaceutical (000650.SZ) announced that as of February 29, 2024, the company had repurchased 14,000,000 shares of the company's shares through a dedicated securities account, accounting for 1.00% of the company's current total share capital (1,399,938,234 shares). The highest transaction price of the repurchase was 6.78 yuan/share, and the minimum transaction price was RMB 5.18 yuan/share, and the total transaction amount was RMB 90,3236 million (excluding transaction fees).
Gelonghui FinanceMar 1 03:01 ET
Renhe Pharmaceutical (000650.SZ): A total cost of 806.18,400 yuan to buy back 12.3 million shares
Gelonghui, February 1, 丨 Renhe Pharmaceutical (000650.SZ) announced that as of January 31, 2024, the company had repurchased a total of 12.3 million shares of the company's shares through a special stock repurchase account, accounting for 0.8786% of the company's current total share capital. The highest transaction price for the repurchase was 6.78 yuan/share, the minimum transaction price was 5.76 yuan/share, and the total amount paid was 806.184,000 yuan (excluding transaction fees).
Gelonghui FinanceFeb 1 03:47 ET
No Data
No Data